Frank Petersen

Author PubWeight™ 40.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 2004 4.98
2 Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 2004 3.43
3 Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin. Cell Host Microbe 2012 2.05
4 Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria. J Med Chem 2010 1.84
5 Structure and vascularization of the acetabular labrum with regard to the pathogenesis and healing of labral lesions. Arch Orthop Trauma Surg 2003 1.30
6 Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. J Antimicrob Chemother 2008 1.28
7 Platelet-derived chemokines in vascular biology. Thromb Haemost 2007 1.27
8 Retracted Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J Immunol 2005 1.16
9 The high-resolution solution structure of epothilone A bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents. Angew Chem Int Ed Engl 2003 1.09
10 Drug discovery from natural products. J Ind Microbiol Biotechnol 2006 1.07
11 Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol 2008 1.05
12 Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration. J Immunol 2002 1.04
13 Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells. J Immunol 2002 1.02
14 Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) 2002 1.00
15 Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients. J Immunol 2004 0.97
16 Molecular pathways of platelet factor 4/CXCL4 signaling. Eur J Cell Biol 2011 0.94
17 Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells. FASEB J 2004 0.93
18 Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 2003 0.92
19 Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J Immunol 2007 0.92
20 Meta-analysis reveals an association of STAT4 polymorphisms with systemic autoimmune disorders and anti-dsDNA antibody. Hum Immunol 2013 0.90
21 The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4. J Immunol 2009 0.88
22 Mechanisms of cilia-driven transport in the airways in the absence of mucus. Am J Respir Cell Mol Biol 2014 0.88
23 Interaction of epothilone B (patupilone) with microtubules as detected by two-dimensional solid-state NMR spectroscopy. Angew Chem Int Ed Engl 2010 0.88
24 Neutrophil adhesion to endothelial cells induced by platelet factor 4 requires sequential activation of Ras, Syk, and JNK MAP kinases. Blood 2005 0.87
25 Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. Blood 2005 0.86
26 Natural products as catalysts for innovation: a pharmaceutical industry perspective. Curr Opin Chem Biol 2011 0.86
27 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway. Am J Pathol 2013 0.85
28 CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes. Innate Immun 2010 0.84
29 FcγRIIA and FcγRIIIB are required for autoantibody-induced tissue damage in experimental human models of bullous pemphigoid. J Invest Dermatol 2010 0.81
30 Euphohelioscopin A is a PKC activator capable of inducing macrophage differentiation. Chem Biol 2012 0.79
31 High-resolution solid-state NMR structure of an anticancer agent. ChemMedChem 2007 0.78
32 Effect of antimicrobial peptides from Apis mellifera hemolymph and its optimized version Api88 on biological activities of human monocytes and mast cells. Innate Immun 2012 0.77
33 The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor. J Interferon Cytokine Res 2002 0.76
34 CXCL4-induced monocyte survival, cytokine expression, and oxygen radical formation is regulated by sphingosine kinase 1. Eur J Immunol 2010 0.76
35 A novel preclinical model for rheumatoid arthritis research. Arthritis Res Ther 2010 0.75
36 Retraction: Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J Immunol 2011 0.75
37 Eupalinilide E inhibits erythropoiesis and promotes the expansion of hematopoietic progenitor cells. ACS Chem Biol 2013 0.75